Vanguard Group’s Ginkgo Bioworks DNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26.8M | Buy |
2,381,125
+250,118
| +12% | +$2.81M | ﹤0.01% | 2417 |
|
|
2025
Q1 | $12.1M | Buy |
2,131,007
+117,449
| +6% | +$669K | ﹤0.01% | 2742 |
|
|
2024
Q4 | $19.8M | Sell |
2,013,558
-592,205
| -23% | -$5.82M | ﹤0.01% | 2588 |
|
|
2024
Q3 | $21.2M | Sell |
2,605,763
-136,358,278
| -98% | -$1.11B | ﹤0.01% | 2567 |
|
|
2024
Q2 | $46.5M | Buy |
138,964,041
+13,107,377
| +10% | +$4.38M | ﹤0.01% | 2179 |
|
|
2024
Q1 | $146M | Sell |
125,856,664
-6,923,431
| -5% | -$8.03M | ﹤0.01% | 1673 |
|
|
2023
Q4 | $224M | Buy |
132,780,095
+463,096
| +0.3% | +$783K | ﹤0.01% | 1437 |
|
|
2023
Q3 | $239M | Buy |
132,316,999
+4,016,221
| +3% | +$7.27M | 0.01% | 1338 |
|
|
2023
Q2 | $239M | Buy |
128,300,778
+17,409,445
| +16% | +$32.4M | 0.01% | 1377 |
|
|
2023
Q1 | $147M | Buy |
110,891,333
+9,370,053
| +9% | +$12.5M | ﹤0.01% | 1619 |
|
|
2022
Q4 | $172M | Buy |
101,521,280
+15,646,253
| +18% | +$26.4M | ﹤0.01% | 1512 |
|
|
2022
Q3 | $268M | Sell |
85,875,027
-860,005
| -1% | -$2.68M | 0.01% | 1205 |
|
|
2022
Q2 | $206M | Buy |
86,735,032
+57,401,650
| +196% | +$137M | 0.01% | 1404 |
|
|
2022
Q1 | $118M | Sell |
29,333,382
-212,725
| -0.7% | -$857K | ﹤0.01% | 1849 |
|
|
2021
Q4 | $246M | Buy |
+29,546,107
| New | +$246M | 0.01% | 1474 |
|